Delivery Order SPE2DB22D3301-SPE2DB25FY0VS

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $52K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,605.47 firm fixed-price delivery order is for the supply of Fosamax 70 mg tablets, a medication used to treat osteoporosis. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $12,833.65 firm fixed price delivery order is for the supply of Fosamax 70 mg tablets, a brand name pharmaceutical product, to support military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,899.56 firm fixed-price delivery order contract is for the supply of FOSAMAX 70 MG Tablets to support federal healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
The federal contract award, SPE2DB20D3103|SPE2DB25FM7T0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,998.24 firm-fixed-price delivery order contract, which does not have a set-aside designation, is for the supply of Fosamax 70 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,739.23 Firm Fixed Price Delivery Order contract has an ultimate completion date of November 29, 2023 and covers the supply of Fosamax 70 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the supply of Fosamax 70 mg tablets to the Defense Logistics Agency (DLA). The $3,092.93 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The $98,091.89 firm fixed-price delivery order is for the provision of Fosamax 70 mg tablets, a medication used to treat osteoporosis. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,960.06 firm fixed-price delivery order contract is for FOSAMAX 70 MG TABLET UU 4S, a medication used to treat osteoporosis. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order under a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,664.75, is for the supply of Fosamax 70 mg tablets to support federal healthcare programs. The IDC held by AmerisourceBergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through November 2026. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,795.69 firm fixed-price contract is for the provision of Fosamax 70 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY0VS
    Delivery Order

This federal contract award, SPE2DB22D3301|SPE2DB25FY0VS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,268.87 firm fixed-price delivery order covers the supply of Fosamax 70 mg tablets, a medication used to treat osteoporosis.

The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, encompasses critical medical commodities across multiple therapeutic areas. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/30/25, 10:02 AM